Skip to main content
DB

Digital Biology

This company develops frontier technology to measure and modify cellular function using molecular engineering. Their platform maps biological interactions in their native context, linking cell and tissue phenotypes to underlying molecules for actionable insights. They enable functional screening and characterization of biotherapeutics and genetic medicines directly within biological systems.

Boston, United StatesFounded 202219700+ followers
Updated 4 months ago

Funding

$0 raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Founders

Founder details are not available yet.

Product

Problem

Current methods for measuring biological interactions often fail to capture the complexity of cellular systems in their native context. This limitation hinders the ability to fully understand and optimize the function of biotherapeutics, slowing down the development of effective next-generation therapies.

Solution

Digital Biology offers a precision measurement platform that uses molecular engineering to map biological interactions within cells and tissues. This technology provides a high-resolution view of cellular function, linking cell and tissue phenotypes directly to underlying molecules. By enabling functional screening of genetically encoded systems at scale, the platform allows strategic partners to screen, characterize, and optimize therapeutic interactions directly within biological systems. The platform captures nucleotide resolution insights from patient tissues and provides high-resolution molecular measurements, including biodistribution profiles of genetic medicines.

Target Audience

The primary target audience includes strategic partners developing cutting-edge biotherapeutics, as well as researchers and clinicians seeking to decipher disease mechanisms in patient tissues.

Features

  • Molecular engineering techniques to map biological interactions in their native context
  • Functional screening of genetically encoded systems at scale
  • Nucleotide resolution insights from archival patient tissues
  • High-resolution molecular measurements, including biodistribution profiles of genetic medicines
  • Direct linking of cell and tissue phenotypes to underlying molecules
This profile is AI-generated and may contain inaccuracies.